Skip to main content
Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
266.40
+5.00 (1.91%)
Apr 15, 2025, 5:29 PM CET

STO:SOBI Revenue

In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B SEK with 17.65% growth. Swedish Orphan Biovitrum AB had revenue of 7.44B in the quarter ending December 31, 2024, with 8.65% growth.

Revenue
26.03B
Revenue Growth
+17.65%
P/S Ratio
3.52
Revenue / Employee
14.41M
Employees
1,806
Market Cap
91.49B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Getinge AB 34.76B
Sectra AB 3.30B
Camurus AB 1.87B
Medicover AB 23.97B
Vitrolife AB 3.61B
Bonesupport Holding AB 898.73M
Vimian Group AB 4.29B
Elekta AB 17.88B
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News